New chemo spray aims to ease suffering from abdominal cancer spread
NCT ID NCT04956068
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new method called PIPAC that sprays chemotherapy directly into the abdomen as a fine mist. It is for people with advanced cancer that has spread to the lining of the belly and who cannot have surgery to remove it. The goal is to see if this approach is safe and can help reduce symptoms. About 25 adults will take part in this early-phase trial in Singapore.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Center Singapore
Singapore, 169690, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
- New radiation technique targets stomach and ovarian cancer spread without surgery
- New chemo spray shows promise for Hard-to-Treat abdominal cancers
- Could chemo around surgery beat cancer spread in the belly?
- PET scans may improve chemo decisions for abdominal cancer patients
- Fish oil drink before surgery may cut complications, tiny study hints